Volume 20, Number 4—April 2014
Research
Rotavirus Surveillance in Urban and Rural Areas of Niger, April 2010–March 2012
Anne-Laure Page
, Viviane Jusot, Abdoul-Aziz Mamaty, Lagare Adamou, Jérôme Kaplon, Pierre Pothier, Ali Djibo, Mahamane L. Manzo, Brahima Toure, Céline Langendorf, Jean-Marc Collard, and Rebecca F. Grais
, Viviane Jusot, Abdoul-Aziz Mamaty, Lagare Adamou, Jérôme Kaplon, Pierre Pothier, Ali Djibo, Mahamane L. Manzo, Brahima Toure, Céline Langendorf, Jean-Marc Collard, and Rebecca F. Grais
Table 5
Weighted analysis of rotavirus genotypes identified during a 2-year surveillance study in Niamey and Maradi region, Niger, April 2010–March 2012
| Genotype and G- and P-type | April 2010–March 2011 |
April 2011–March 2012 |
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Niamey, n = 121 |
Maradi region, n = 194 |
Niamey, n = 49 |
Maradi region, n = 85 |
|||||||||
| No. (%) | 95% CI | No. (%) | 95% CI | No. (%) | 95% CI | No. (%) | 95% CI | |||||
| Genotype | ||||||||||||
| G1P[8] | 6 (4.8) | 2.1–10.5 | 3 (1.8) | 0.6–5.7 | 1 (1.8) | 0.2–12.4 | 4 (3.8) | 1.3–10.6 | ||||
| G2P[4] | 30 (25.1) | 18.0–33.9 | 137 (60.5) | 51.6–68.8 | 0 | – | 0 | – | ||||
| G2P[6] | 9 (6.2) | 3.2–11.6 | 5 (3.7) | 9.0–1.6 | 0 | 0 | 2 (2.7) | 0.6–10.3 | ||||
| G6P[6] | 12 (9.4) | 5.4–16.1 | 0 | – | 1 (1.3) | 0.2–9.2 | 0 | – | ||||
| G9P[8] | 8 (5.9) | 2.9–11.6 | 7 (5.9) | 2.8–11.9 | 0 | – | 1 (1.3) | 0.2–8.9 | ||||
| G12P[8] | 36 (31.4) | 23.4–40.5 | 19 (10.9) | 6.6–17.5 | 43 (89.2) | 76.3–95.5 | 56 (64.1) | 52.4–74.4 | ||||
| Others* | 15 (13.2) | 8.0–21.0 | 13 (10.0) | 5.4–17.8 | 2 (2.7) | 0.6–11.4 | 9 (12.3) | 6.1–23.3 | ||||
| Mixed |
5 (4.0) |
1.6–9.6 |
10 (7.1) |
3.5–13.7 |
2 (5.1) |
1.2–19.3 |
13 (15.8) |
9.1–26.1 |
||||
| G-type† | ||||||||||||
| G1 | 10 (8.1) | 4.3–14.7 | 4 (2.7) | 1.0–7.1 | 2 (4.8) | 1.1–18.7 | 4 (3.7) | 1.3–10.6 | ||||
| G2 | 51 (41.9) | 33.2–51.1 | 148 (66.5) | 57.5–74.4 | 0 | – | 6 (7.9) | 3.5–16.7 | ||||
| G3 | 3 (2.7) | 0.8–8.5 | 17 (16.0) | 10.0–24.7 | 0 | – | 5 (6.0) | 2.4–14.3 | ||||
| G6 | 13 (10.3) | 6.0–17.2 | 1 (0.1) | 0.0–1.0 | 2 (3.0) | 0.7–12.3 | 0 | – | ||||
| G9 | 10 (7.2) | 3.8–13.1 | 13 (11.1) | 6.4–18.5 | 1 (2.1) | 0.3–14.2 | 9 (10.0) | 5.0–18.7 | ||||
| G12 |
36 (31.4) |
23.4–40.5 |
20 (11.1) |
6.8–17.6 |
46 (95.2) |
85.3–98.5 |
71 (82.8) |
72.3–89.9 |
||||
| P-type† | ||||||||||||
| P[4] | 32 (27.0) | 19.7–35.9 | 145 (67.8) | 59.1–75.4 | 0 | – | 0 | – | ||||
| P[6] | 27 (20.1) | 13.9–28.0 | 14 (9.7) | 5.6–16.2 | 2 (2.2) | 0.5–9.0 | 13 (17.6) | 10.1–28.9 | ||||
| P[8] | 63 (53.7) | 44.6–62.6 | 38 (23.6) | 16.9–31.9 | 47 (97.8) | 91.0–99.5 | 72 (83.7) | 72.9–90.7 | ||||
*Including G1P[6] (2), G2P[8] (9), G3P[4] (5), G3P[6] (7), G3P[8] (2), G6P[8] (3), and G12P[6] (7).
†Mixed infections counted in each G- or P-type found, potentially leading to a total number greater than N.
Page created: March 12, 2014
Page updated: March 12, 2014
Page reviewed: March 12, 2014
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.